-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
TNF Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
- TNF Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$6.2M, a 484% decline year-over-year.
- TNF Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$2.78M, a 200% decline year-over-year.
- TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.1M, a 15262% increase from 2022.
- TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $85.4K.
- TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.08M, a 765588% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)